Association between the histopathologic findings of a zero-time biopsy and the donor kidney function 24 hours and a year after nephrectomy

Karla I. Zarco Arreola, Israel D. Campos Gonzales, Blanca J. Martinez Chagolla, Jorge A. Quiroz Pérez, Luis E. Suarez Luna


Background: The living-donor transplantation (LDT) is essential to provide patients with chronic kidney disease (CKD) a superior quality of life and improve their lifespan. Recent investigations prove that the living donors (LD) have a risk of developing CKD, without there being a way to anticipate it. The zero-time biopsies provide valuable information that may contribute to this objective since they report histopathologic findings of subclinical chronic damage. 

Methods: Retrospective, observational and analytical study. The information from the medical files and pathology department of LD attended at “Dr. Miguel Silva” general hospital from January 2006 to January 2018 was analyzed. The glomerular filtrate rate was obtained 24 hours and a year after nephrectomy and was estimated based on CDK-EPI. The comparison among groups was made through Mann-Whitney testing for continuous numeric. A value of p<0.05 was considered statistically significant.

Results: A total of 56 medical files were studied, 29 of which had a report of biopsy, the general prevalence of histologic anomalies was 65%. We found that those patients that showed a lower value in the GFR after 24 hours also showed lower GFR the next year, likewise a narrow and statistically significant correlation between the creatinine levels in the immediate post-operative period and the following year was found. In the same way, we found that the higher the dropping rate of GFR after 24 hours of nephrectomy, the lower the GFR a year after donation being statistically significant. It was decided to divide the sample into two groups (with and without histological alterations), it was found that a year later the GFR in the group with histological damage was less (75.6±21.7 ml/min/1.73 m2) compared to the group without damage (85.2±11.6 ml/min/1.73 m2) with a p<0.05 (Figure 4) and finally, there is association between the age group and the GFR the year after donation.

Conclusions: Among the candidates for LDT, the zero-time biopsy alterations, the age >36 years, the dropping of the GFR >43%, the GFR and the creatinine levels after 24 hours of nephrectomy were associated with a reduction of the GFR the year after nephrectomy.


CKD, Kidney transplant, Zero biopsy

Full Text:



García-García G, Harden P, Chapman J, Abraham G, Beerkens P, Chapman JR et al. The global role of kidney transplantation. Nefrologia. 2012;32(1):1-6.

Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR et al. Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med. 2016;374(5):411-21.

Kiberd BA. Estimating the long-term impact of kidney donation on life expectancy and end stage renal disease. Transplant Res. 2013;2(1):1-6.

Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O et al. Long-term risks for kidney donors. Kidney Int. 2014;86(1):162-7.

Naesens M. Zero-time renal transplant biopsies: A comprehensive review. Transplantation. 2016;100(7):1425-39.

Burballa C, Crespo M, Redondo-Pachón D, Pérez-Sáez MJ, Mir M, Arias-Cabrales C et al. MDRD o CKD-EPI en la estimación del filtrado glomerular del donante renal vivo. Nefrologia. 2018;38(2):220-1.

Burballa C, Crespo M, Redondo-Pachón D, Pérez-Sáez MJ, Arias-Cabrales C, Mir M et al. Factors associated with the compensation of renal function after nephrectomy of a kidney donor. Nefrologia. 2018;38(5):528-34.

Domínguez-Gil B, Pascual J. El trasplante renal de donante vivo en España: Una gran oportunidad. Nefrologia. 2008;28(2):143-7.

Bellini C, Stratigos DPs. The Effect of Donors’ Demographic Characteristics in Renal Function Post-Living Kidney Donation. Analysis of a UK Single Centre Cohort. J Clin Med. 2019;8(6):883.

Cronin R, Nicholas D, Yung Peng RK. HHS Public Access. Physiol Behav. 2017;176(3):139-48.

Rodrigo Orozco B. Prevención y tratamiento de la enfermedad renal crónica (ERC). Rev Médica Clínica las Condes. 2010;21(5):779-89.

Anothaisintawee T, Rattanasiri S, Ingsathit A, Attia J, Thakkinstian A. Prevalence of chronic kidney disease: A systematic review and meta-analysis. Clin Nephrol. 2016;71(3):244-54.

Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M et al. Chronic kidney disease. Nat Rev Dis Prim. 2017;3.

Amato D, Alvarez-Aguilar C, Castañeda-Limones R, Rodriguez E, Avila-Diaz M, Arreola F et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl. 2005;68(97):11-7.

Obrador GT, García-García G, Villa AR, Rubilar X, Olvera N, Ferreira E et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US. Kidney Int Suppl. 2010;77(116).

Andrés A. Indicaciones y contraindicaciones de la donación renal de vivo. Nefrologia. 2010;30(2):30-8.

Sánchez-Escuredo A, Barajas A, Revuelta I, Blasco M, Cofan F, Esforzado N et al. Trasplante renal de donante vivo entre gemelos monocigotos sin inmunosupresión de mantenimiento. Nefrologia. 2015;35(4):358-62.

Ministerio de sanidad servicios sociales e igualdad. El Registro Mundial de Trasplantes, que gestiona la ONT, eleva a 126.670 los trasplantes realizados en el mundo en 2016, con un aumento histórico de un-5, 8%. Ont. 2016;1-5.

Correa-Rotter R, Morales-Buenrostro L. Protocolo de trasplante renal 2015. Inst Nac Ciencias Médicas y Nutr Salvador Zubirán. 2015;63.

Levey AS, Inker LA. GFR evaluation in living kidney donor candidates. J Am Soc Nephrol. 2017;28(4):1062-71.

Aguilar MA, Barrera A, Gómez C, González G, Méndez A, Torres LP. Guía de práctica clínixa GPC Tratamiento sustitutivo de la funcion renal. Insuficiencia renal cronica segundo y tercer nivel de atención. 2014;58.

Bjornstad P, Karger AB, Maahs DM. Measured GFR in Routine Clinical Practice-The Promise of Dried Blood Spots. Adv Chronic Kidney Dis. 2018;25(1):76-83.

Bermúdez RM, Sanjuán JB, Samper AO, Castán JAB, García SG. Valoraci n de la nueva ecuaci??n CKD-EPI para la estimación del filtrado glomerular. Nefrologia. 2012;32(2):273-4.

Lenihan CR, Busque S, Derby G, Blouch K, Myers BD, Tan JC. Longitudinal study of living kidney donor glomerular dynamics after nephrectomy. J Clin Invest. 2015;125(3):1311-8.

Moore DR, Serur D, Rudow DL, Rodrigue JR, Hays R, Cooper M. Living donor kidney transplantation: Improving efficiencies in live kidney donor evaluation-recommendations from a consensus conference. Clin J Am Soc Nephrol. 2015;10(9):1678-86.

Muzaale AD, Massie AB, Wang MC, Montgomery RA, McBride MA, Wainright JL et al. Risk of end-stage renal disease following live kidney donation. J Am Med Assoc. 2014;311(6):579-86.

Govantes MÁG, Palomo PP. Estudio y selección del donante vivo de riñón. Nefrologia. 2010;30(2):47-59.

Roufosse C, Simmonds N, Clahsen-Van Groningen M, Haas M, Henriksen KJ, Horsfield C et al. A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology. Transplantation. 2018;102(11):1795-814.

Rook M, Hofker HS, Van Son WJ, Homan Van Der Heide JJ, Ploeg RJ, Navis GJ. Predictive capacity of pre-donation GFR and renal reserve capacity for donor renal function after living kidney donation. Am J Transplant. 2006;6(7):1653-9.